A typical Retatrutide titration might progress as: 1 mg weeks 1-4, 2 mg weeks 5-8, 4 mg weeks 9-12, 8 mg weeks 13-16, and 12 mg weeks 17 onward
Blue Cross and Blue Shield of Massachusetts announced in April it would begin covering GLP-1 drugs for diabetes only
Keeping a detailed log of spray counts, timing, and any observed variance helps normalize results across a larger dataset
The key lies in selecting activities that load the healing tissue progressively without exceeding its current tolerance
By targeting these key areas, Tirzepatide helps reduce food intake, control blood sugar, and promote weight loss, making it a powerful tool for those looking to manage their weight and improve their overall health